Researchers have identified two oncogenes that drive the development of medulloblastoma brain cancer.
A new synthetic peptide has the potential to deliver medications through the blood brain barrier.
Researchers find aspirin intake correlates with halted growth of vestibular schwannomas.
A genetic mutation associated with a number of cancers could also be responsible for papillary craniopharyngioma, a rare but debilitating brain tumor, a new study reports.
Researchers demonstrate melanoma differentiation associated gene, mda-9/syntenin is a driving force behind the aggressive and invasive nature of glioblastoma brain cancer.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
A new study could pave the way for more effective treatment of infantile ETMR/ETANTR brain cancer.
Researchers discover the mTOR pathway is highly active in many cases of pediatric low-grade glioma. Blocking the pathway lead to a decreased growth of the brain tumors.
A new study reports a novel combination of two targeted drugs dramatically slowed the growth of brain cancer tumors and significantly extended survival in mouse models.